Adjuvant Anti-PD-1 Therapy in Resected Hepatocellular Carcinoma

Clinical trial NCT07379489 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07379489
Sponsor: Tongji Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

HCC Adjuvant Therapy Recurrence Immune Checkpoint Inhibitor

Start date: 2026-01-31
Primary completion: 2029-12-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.